PUBLICATIONS
98
peer-reviewed publications
From Target to Therapeutic —
One Ion Channel at a Time.
Our laboratory has targeted ion channels in allergic disease and sensory disorders, with three IND-approved candidates to date.
Every project begins the same way: identify the channel, map the binding site, validate the mechanism, advance the candidate.
3
IND-approved candidates to date
9
patents (Korea/PCT/US)
Selected Publications — High-Impact Work
CANCER RESEARCH · 2025
IF 16.6 (2024 JCR)
Oncology #16/328
Nutrient Availability Dictates Cancer
Metabolism-Based Therapeutic Responses
to Non-oncology Drugs
Pyun WY et al., Nam JH (Co-corresponding)
BIOMEDICINE & PHARMACOTHERAPY · 2025
IF 7.5 (2024 JCR)
Pharmacology & Pharmacy #19/352
Polypharmacological effects of honokiol
on allergic rhinitis: Modulation of
TMEM16A, TRPV1, and calcium signaling
Phan HTL et al., Nam JH (Co-corresponding)
PNAS · 2024
IF 9.1 (2024 JCR)
Multidisciplinary Sciences #14/135
Distinct modulation of calcium-activated
chloride channel TMEM16A by a novel
drug-binding site
Roh JW et al., Nam JH (Co-corresponding)
PAIN · 2024
IF 5.5 (2024 JCR)
Anesthesiology #6/68
Physiological profiling of cannabidiol
reveals profound inhibition of
sensory neurons
Chahyadinata G et al., Nam JH (Co-first)
EXPERIMENTAL & MOLECULAR MEDICINE · 2023
IF 12.8 (2024 JCR)
Biochemistry & Molecular Biology #14/320
Overlooked KCNQ4 variants augment
the risk of hearing loss
Oh KS et al., Nam JH (Co-corresponding)
PHYTOMEDICINE · 2023
IF 8.3 (2024 JCR)
Integrative & Complementary Medicine #1/45
Multi-target modulation of ion channels
underlying the analgesic effects of
alpha-mangostin in dorsal root ganglion
neurons
Kim SE et al., Nam JH (Co-corresponding)